Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Submitted by
admin
on January 4, 2018 - 11:01am
Source:
Drug Delivery Business News
News Tags:
Mylan Labs
Momenta Pharmaceuticals
Regeneron
Eylea
biosimilars
diabetic macular edema
wet age-related macular degeneration
M710
Headline:
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Do Not Allow Advertisers to Use My Personal information
